Funding, Valuation & Revenue

1 Fundings

Voxa's latest funding round was a Option/Warrant for $0.09M on October 8, 2015.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/8/2015

Option/Warrant

$0.09M

Undisclosed Investors

$XXM

0

FY undefined

1

Date

10/8/2015

Round

Option/Warrant

Amount

$0.09M

Investors

Undisclosed Investors

Valuation

$XXM

Revenue

0

FY undefined

Sources

1

Start free trial
New call-to-action
New call-to-action

Compare Voxa to Competitors

Space Tango Logo
Space Tango

Space Tango develops automated systems for health and technology manufacturing in the space industry. The company provides facilities and support for research and development, as well as manufacturing in microgravity environments. Space Tango serves sectors interested in space-based research and development and healthcare innovation. It was founded in 2014 and is based in Lexington, Kentucky.

Starlab Logo
Starlab

Starlab Space focuses on the development and operation of a platform for microgravity research and technological advancement. The company has a space station designed for scientific experimentation and product development in low Earth orbit, serving sectors including biopharma, advanced manufacturing, and space exploration. Starlab Space also provides operational support using AI, robotics for maintenance, and services for crew members. It was founded in 2023 and is based in Houston, Texas.

I
Interstellar Lab

Interstellar Lab develops biospheric systems for autonomous plant cultivation in terrestrial and extraterrestrial environments. The company provides platforms that automate the cultivation process by adjusting temperature, humidity, light, and nutrients to support plant growth with human intervention. Interstellar Lab's technology supports plant-based ingredient production for industries like health, beauty, and food & beverage, and has been noted by NASA for potential use in space. It was founded in 2018 and is based in Paris, France.

Ursa Bio Logo
Ursa Bio

Ursa Bio operates as a biotech company focused on addressing the physiological challenges of spaceflight within the space and biotechnology sectors. The company develops interventions to mitigate health risks for astronauts, such as muscle atrophy, bone density loss, cognitive impairment, and vision issues caused by space conditions. Ursa Bio's offerings include medical advancements in longevity, regenerative medicine, and drug development, utilizing spaceflight as a unique environment for research. It was founded in 2021 and is based in New York, New York.

S
Space Cargo Unlimited

Space Cargo Unlimited conducts microgravity research for commercial applications in various sectors. The company provides in-space manufacturing and research services to develop products and processes in agriculture, pharmaceuticals, and material sciences. Space Cargo Unlimited serves the agriculture, medicine, and pharmaceutical sectors with its microgravity research and manufacturing capabilities. It was founded in 2014 and is based in Luxembourg.

Owlstone Medical Logo
Owlstone Medical

Owlstone Medical focuses on breath analysis for disease detection within the healthcare sector. The company develops technology for discovering and validating biomarkers in breath, employing chemical analysis and sensor technology for diagnosis. Owlstone Medical's products and services are intended for academic, clinical, and pharmaceutical research partners involved in developing breath-based diagnostics. It was founded in 2004 and is based in Cambridge, United Kingdom.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.